Table A2.
Chemotherapy Regimens Received by Excluded Patients With Early-Stage Breast Cancer and Proportion of Patients Hospitalized for Chemotherapy-Related Reasons (neutropenia, infection, fever, thrombocytopenia, anemia, adverse effects of chemotherapy, dehydration and delirium)
| Chemotherapy Regimen | Patients Hospitalized |
|||
|---|---|---|---|---|
| ≥ Age 65 Years (n = 7,354) |
≤ Age 65 Years (n = 12,506) |
|||
| No. | % | No. | % | |
| Trastuzumab containing | 1,737 | 19.8 | 3,688 | 7.9 |
| Other anthracycline and taxane containing | 2,283 | 23.5 | 4,552 | 10.7 |
| Anthracycline without a taxane | 812 | 24.9 | 1,939 | 9.2 |
| Cyclophosphamide, methotrexate, and fluorouracil | 1,456 | 15.2 | 661 | 4.7 |
| Other | 1,066 | 24.3 | 1,666 | 8.3 |